Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 266 | nsp14:N266S; | CL-3e; |
| 388 | nsp14:N388D; | CL-3b; |
| 388 | nsp14:N388S; | CL-3b; |
| 3 | nsp14:N3H; | CL-3c; |
| 3 | nsp14:N3S; | CL-3e; |
| 408 | nsp14:N408K; | CL-1a_3d;CL-3b; |
| 408 | nsp14:N408S; | CL-3f; |
| 422 | nsp14:N422-; | CL-3b; |
| 422 | nsp14:N422S; | CL-1b; |
| 438 | nsp14:N438-; | CL-3b; |
| 438 | nsp14:N438K; | CL-3b;CL-3c; |
| 438 | nsp14:N438S; | CL-3c;CL-3d; |
| 438 | nsp14:N438T; | CL-1b; |
| 478 | nsp14:N478-; | CL-3b;CL-3e; |
| 489 | nsp14:N489-; | CL-1a_3e;CL-3b;CL-3c;CL-3f; |
| 489 | nsp14:N489A; | CL-3b; |
| 489 | nsp14:N489S; | CL-3b;CL-3e; |
| 499 | nsp14:N499-; | CL-3b;CL-3d; |
| 521 | nsp14:N521-; | CL-3f; |
| 63 | nsp14:N63H; | CL-3e; |
| 63 | nsp14:N63K; | CL-3b; |
| 63 | nsp14:N63S; | CL-3e; |
| 67 | nsp14:N67S; | CL-3d; |
| 71 | nsp14:N71-; | CL-3b; |
| 121 | nsp14:P121-; | CL-1b;CL-3b;CL-3e; |
| 121 | nsp14:P121A; | CL-3e; |
| 121 | nsp14:P121S; | CL-2;CL-3d;CL-3e; |
| 128 | nsp14:P128-; | CL-3b;CL-3e; |
| 128 | nsp14:P128S; | CL-3d;CL-3e;CL-3f; |
| 142 | nsp14:P142-; | CL-1b;CL-3b;CL-3f; |
| 142 | nsp14:P142H; | CL-1a_3f;CL-3b; |
| 142 | nsp14:P142L; | CL-1b;CL-3e;CL-3f; |
| 151 | nsp14:P151-; | CL-1a_3e;CL-3e; |
| 151 | nsp14:P151L; | CL-3d;CL-3e;CL-3f; |
| 151 | nsp14:P151Q; | CL-1a_3d; |
| 151 | nsp14:P151S; | CL-3c;CL-3d;CL-3e;CL-3f; |
| 151 | nsp14:P151T; | CL-3b; |
| 158 | nsp14:P158L; | CL-1b;CL-3e;CL-5; |
| 203 | nsp14:P203S; | CL-1b;CL-2;CL-3c;CL-3d;CL-3e;CL-3f; |
| 239 | nsp14:P239A; | CL-3b; |
| 239 | nsp14:P239L; | CL-3d;CL-3e; |
| 24 | nsp14:P24S; | CL-3e; |
| 24 | nsp14:P24T; | CL-3d;CL-3e;CL-5; |
| 342 | nsp14:P342L; | CL-3f; |
| 355 | nsp14:P355L; | CL-3e; |
| 355 | nsp14:P355S; | CL-3c;CL-3d;CL-3e; |
| 393 | nsp14:P393-; | CL-3e; |
| 393 | nsp14:P393L; | CL-1a;CL-1a_3e;CL-3e;CL-3f; |
| 412 | nsp14:P412-; | CL-3b;CL-3e;CL-3f; |
| 412 | nsp14:P412H; | CL-3d; |
Page 197 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com